Skip to content

EchoLaser for men on blood thinners or with a catheter

What the studies show about EchoLaser in men who have a catheter, men who take blood thinners and men at high surgical risk.

Dr. Petronio Melo, urologistA reference in enlarged prostate (BPH) treatment
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 16, 2026
Book a consultation
Drawing of a prostate with a catheter and a blister pack of pills
On this page

Quick answer

Men who have a catheter because of an enlarged prostate can have EchoLaser in selected cases. In small series, the catheter was removed after treatment in 56% to 90% of these men.2,3,4,5,6 Men on anticoagulants or antiplatelet drugs can also have it: the studies included men taking these drugs, with no serious complications.2,4 In my practice, the decision about the blood thinner for EchoLaser is made case by case, together with the doctor who prescribed it.

For men with a catheter

When an enlarged prostate closes the passage and urine cannot come out, the bladder needs a catheter. If the catheter cannot be removed, the prostate needs treatment. Urinary retention has its own page.

In EchoLaser, thin needles go in through the perineum, guided by ultrasound, and carry laser fibers into the prostate. The heat coagulates the tissue, at a safe distance from the urethra, and the prostate shrinks over the following months.1,2

Schematic animation of EchoLaser. The number of needles varies from case to case.

Studies of men with a catheter are still small:

StudyMen with a catheterResult
Florence, 202414 of 100 men treated9 voided again without a catheter (64%); of the 5 who still needed it, 3 had it removed after surgery through the urethra2
Turin, 202423 of 40 men at high surgical riskCatheter removed in 13 (56.5%)3
Florence, 20246 of 23 men with several illnesses4 voided on their own4
Italy, 202610 of 31 men with a median lobe9 returned to normal voiding5
Florence, 20265 of 43 men with a prostate of 80 g or moreCatheter removed in 3 (60%)6

None of these studies had a comparison group. Three come from the same center, in Florence, and may include some of the same patients. The prostate size reported in the studies has to be assessed case by case.

In a consensus of EchoLaser experts, 77% agreed that the treatment can be used in men with a catheter.7 This consensus was made by doctors who use the technique, and it carries less weight than a comparative study.

Bladder strength

A bladder that has stayed full for a long time can lose strength. If it does not contract, removing the prostate obstruction may not be enough for urine to come out. For this reason, the consensus suggested a urodynamic study only for men with a catheter, to see whether the bladder still contracts.7 In the Florence study, men with a catheter were treated only after this test, which ruled out a very weak bladder.2

How long the catheter stays afterward

In men who already had a catheter, the consensus recommended keeping it for 7 to 15 days after treatment. According to the experts, removal usually happens between 7 days and 1 month.7 The studies in the table do not report how many days the catheter stayed in these men.

When the catheter does not come out, there is still a way forward. In the Florence study, 3 of the 5 men who still had a catheter had it removed after surgery through the urethra.2

For men on anticoagulants or antiplatelet drugs

Anticoagulants and antiplatelet drugs are blood thinners, used for example for arrhythmia or after a stent. In EchoLaser, the needles go in through the perineum and the laser stays at a safe distance from the urethra, which in the Florence study was 8 mm, precisely to avoid blood in the urine and other problems.2

The studies included men who took these drugs:

  • In Florence, 24 of the 100 men took an antiplatelet drug or an anticoagulant. No one had a serious complication.2 The authors write that EchoLaser can be offered to older men with several illnesses without requiring these drugs to be stopped.2
  • In a group of 23 men with several illnesses, from the same center, 18 took an antiplatelet drug or an anticoagulant. No one had a moderate or serious complication.4
  • In Turin, the high-risk men included those with clotting problems from medication or illness. There was one more serious complication (2.5%), and none was life-threatening.3

In a consensus of EchoLaser experts, 96% considered the treatment safe in men on anticoagulants or antiplatelet drugs. The same consensus suggested deciding about stopping them according to each patient's risk of bleeding and of thrombosis.7 In another consensus, of 28 Italian urologists, the panel agreed that EchoLaser has less bleeding after the procedure than TURP.8

The studies are still small and have not compared men who stayed on the drug with men who did not take it. In a report of a single case, a 78-year-old man with a catheter, a very weak heart and two antiplatelet drugs that could not be stopped was treated under local anesthesia, without complications, and was catheter-free in 15 days.10 A single case is not a rule.

In my practice, the decision about the blood thinner for EchoLaser is made case by case, together with the doctor who prescribed it. Never stop or change a medication on your own.

For older men or men at high surgical risk

In a study from Turin, 40 men with a median age of 80 and several illnesses had EchoLaser under local anesthesia and went home the same day. The symptom score (IPSS) fell from 25 to 8 points at 6 months. Almost half (47.5%) had some complication, mostly mild, and only one was more serious.3

In Florence, 23 men with several illnesses, considered unfit for standard surgery, were treated under local anesthesia, without a hospital stay. Treatment failed in 2 (8.5%), and no one had a moderate or serious complication.4

A 2025 review of minimally invasive techniques in men aged 75 or older required at least 50 patients per study and found no EchoLaser study of that size.9

Relief tends to be smaller than with TURP: in a randomized study, urine flow increased by 23.9 mL/s with TURP and 6.0 mL/s with EchoLaser.1 The Italian consensus also recognized a high risk of needing another treatment after EchoLaser.8 This goes into the discussion, alongside the advantage of not needing general anesthesia and of going home the same day.

How I approach it

I have performed EchoLaser since 2025, when the technique arrived in Brazil, and I did one of the first cases in the country. In my practice, the treatment is done under local anesthesia with sedation, with a short hospital admission: you arrive and go home the same day. The decision about the blood thinner is made case by case, together with the doctor who prescribed it.

In men who have a catheter, take blood thinners or have other illnesses, I assess the prostate, the strength of the bladder and what you want to preserve. I also go over the other techniques. In my practice, HoLEP is possible even in men who take anticoagulants, and the European guideline describes laser enucleation as done safely in this group.1 We make the decision together and, when needed, with the doctor who follows the medication. The first consultation can be online, in English.

When to see a urologist

  • If you have a catheter because of your prostate and want to know whether it can come out
  • If an attempt to remove the catheter did not work
  • If you take an anticoagulant or antiplatelet drug and need prostate treatment
  • If you were told you cannot have surgery because of other illnesses

Send your case

If you take blood thinners or have a catheter and would like my opinion on your case before a consultation, fill in the form below. Tell me which medications you use and how long you have had the catheter. It goes to my office, and you will get a reply within 24 hours by email or WhatsApp. The form does not replace a consultation: it helps plan the next step.

Frequently asked questions

Can men with a catheter have EchoLaser?

Yes, in selected cases. In small series of men who had a catheter because of the prostate, it was removed after EchoLaser in 56% to 90% of cases.2,3,4,5,6 These studies had no comparison group, and each case is assessed at the consultation.

How long does the catheter stay afterward in men who already depended on one?

In an expert consensus, the recommendation was to keep the catheter for 7 to 15 days after treatment in men who already had one. Removal usually happens between 7 days and 1 month.7

Do I need a bladder test beforehand?

In men with a catheter, the same consensus suggested a urodynamic study, which shows whether the bladder still has the strength to empty.7 In a study from Florence, men with a catheter were treated only after this test.2

What if the catheter does not come out after EchoLaser?

There are still other options. In the Florence study, 5 of the 14 men who had a catheter still needed it, and 3 of those 5 had it removed after surgery through the urethra.2

Can men on anticoagulants have EchoLaser?

Yes. In my practice, the decision about the blood thinner for EchoLaser is made case by case, together with the doctor who prescribed it. In the studies, men who took anticoagulants or antiplatelet drugs were treated without serious complications.2,4 In an expert consensus, 96% considered the treatment safe in this group.7

Does EchoLaser bleed less than TURP?

In a consensus of 28 Italian urologists experienced with these techniques, the panel agreed that EchoLaser has less bleeding after the procedure than TURP.8 EchoLaser studies have not yet compared men who stayed on the drug with men who did not take it.

I am older and at high surgical risk. Is EchoLaser an option?

It may be. In a study from Turin, 40 men with a median age of 80 and several illnesses were treated under local anesthesia and went home the same day.3 A 2025 review of men aged 75 or older found no EchoLaser studies large enough to be included.9

Who performs EchoLaser in São Paulo?

I am Dr. Petronio Melo, a urologist and robotic surgeon in São Paulo, CRM-SP 157.598 and RQE 70.275. I have performed EchoLaser since 2025, when the technique arrived in Brazil, and I did one of the first cases in the country. In my practice, it is done under local anesthesia with sedation, with a short hospital admission: you arrive and go home the same day. The decision about the blood thinner is made case by case, together with the doctor who prescribed it. My office is in Vila Mariana, and the first consultation can be in person or online, in English.

References

  1. EAU Guidelines on the Management of Non-neurogenic Male LUTS. European Association of Urology; 2026. Treatment chapter. EAU
  2. Lo Re M, Polverino P, Rivetti A, et al. Transperineal laser ablation (TPLA) of the prostate for benign prostatic obstruction: the first 100 patients cohort of a prospective, single-center study. World J Urol. 2024;42(1):402. PubMed
  3. Destefanis P, Sibona M, Vitiello F, et al. Trans-perineal laser ablation of the prostate in high surgical risk patients affected by severe lower urinary tract symptoms related to benign prostatic obstruction. Prostate Cancer Prostatic Dis. 2024;27(4):693-699. PubMed
  4. Polverino P, Lo Re M, Saladino M, et al. Could transperineal interstitial laser ablation of the prostate be the right option for highly-comorbid patients with lower urinary tract symptoms due to benign prostatic obstruction? A preliminary single-center experience focusing on functional and safety outcomes. Minerva Urol Nephrol. 2024;76(5):646-649. PubMed
  5. Ruffo A, Stanojevic N, Crocetto F, et al. Transperineal laser ablation of symptomatic benign prostatic hyperplasia with median-lobe enlargement: a single-center experience. Lasers Surg Med. 2026;58(7):524-531. PubMed
  6. Polverino P, Moscardi L, Lo Re M, et al. Office-based transperineal laser ablation in patients with large prostates (≥80 mL): real-world evidence of safety and efficacy from a prospective single center cohort. Minerva Urol Nephrol. 2026. PubMed
  7. Cocci A, Pezzoli M, Bianco F, et al. Transperineal laser ablation of the prostate as a treatment for benign prostatic hyperplasia and prostate cancer: the results of a Delphi consensus project. Asian J Urol. 2024;11(2):271-279. PubMed
  8. Passarelli F, Castellani D, Secco S, et al. Minimally invasive surgical techniques (MISTs) for benign prostatic hyperplasia: results from a Delphi consensus project to shed light on controversial topics. World J Urol. 2025;43(1):363. PubMed
  9. Ozervarli MF, Oba KC, Yilmaz M, et al. Minimally invasive treatments for benign prostatic hyperplasia in patients over 75: a systematic review. World J Urol. 2025;43(1):703. PubMed
  10. Abou Taleb AA. Transperineal laser ablation for 300-gram benign prostatic hyperplasia in an inoperable high-risk patient: expanding the therapeutic horizon. Urol Case Rep. 2026;68:103591. PubMed

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation5.0186 Google reviews

Related guides